1. Home
  2. EXAS vs SQM Comparison

EXAS vs SQM Comparison

Compare EXAS & SQM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXAS
  • SQM
  • Stock Information
  • Founded
  • EXAS 1995
  • SQM 1968
  • Country
  • EXAS United States
  • SQM Chile
  • Employees
  • EXAS N/A
  • SQM N/A
  • Industry
  • EXAS Medical Specialities
  • SQM Mining & Quarrying of Nonmetallic Minerals (No Fuels)
  • Sector
  • EXAS Health Care
  • SQM Industrials
  • Exchange
  • EXAS Nasdaq
  • SQM Nasdaq
  • Market Cap
  • EXAS 12.3B
  • SQM 9.9B
  • IPO Year
  • EXAS N/A
  • SQM 1993
  • Fundamental
  • Price
  • EXAS $49.33
  • SQM $38.13
  • Analyst Decision
  • EXAS Strong Buy
  • SQM Hold
  • Analyst Count
  • EXAS 17
  • SQM 8
  • Target Price
  • EXAS $73.07
  • SQM $48.69
  • AVG Volume (30 Days)
  • EXAS 3.3M
  • SQM 930.2K
  • Earning Date
  • EXAS 11-05-2024
  • SQM 11-19-2024
  • Dividend Yield
  • EXAS N/A
  • SQM 5.54%
  • EPS Growth
  • EXAS N/A
  • SQM N/A
  • EPS
  • EXAS N/A
  • SQM 0.09
  • Revenue
  • EXAS $2,692,328,000.00
  • SQM $5,530,033,000.00
  • Revenue This Year
  • EXAS $12.41
  • SQM N/A
  • Revenue Next Year
  • EXAS $11.64
  • SQM $35.80
  • P/E Ratio
  • EXAS N/A
  • SQM $409.14
  • Revenue Growth
  • EXAS 11.91
  • SQM N/A
  • 52 Week Low
  • EXAS $40.62
  • SQM $32.24
  • 52 Week High
  • EXAS $79.62
  • SQM $64.62
  • Technical
  • Relative Strength Index (RSI)
  • EXAS 22.62
  • SQM 44.03
  • Support Level
  • EXAS $48.02
  • SQM $36.73
  • Resistance Level
  • EXAS $52.32
  • SQM $39.77
  • Average True Range (ATR)
  • EXAS 2.86
  • SQM 1.34
  • MACD
  • EXAS -1.89
  • SQM -0.16
  • Stochastic Oscillator
  • EXAS 5.28
  • SQM 26.88

About EXAS Exact Sciences Corporation

Exact Sciences Corporation, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test, a noninvasive stool-based DNA test, is a pre-cancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, or MRD, colorectal cancer screening, and multicancer screening.

About SQM Sociedad Quimica y Minera S.A.

Sociedad Quimica y Minera de Chile is a Chilean commodities producer with significant operations in lithium (primarily used in batteries for electric vehicles and energy storage systems), specialty and standard potassium fertilizers, iodine (primarily used in X-ray contrast media), and solar salts. The company extracts these materials through its high-quality salt brine deposits and caliche ore. SQM is developing a hard rock lithium project in Australia and expanding its lithium refining assets in China.

Share on Social Networks: